Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to SYRS Stock Lookup

Syros Pharmaceuticals (SYRS) – Analyst EPS View

Apr 10, 2017 09:41 AM Oppenheimer Reiterates Outperform Rating and $28 PT on Syros Pharma (SYRS); 'FDA Accepts IND for SY-1365'

Back to SYRS Stock Lookup